Adicet Bio (ACET)
(Delayed Data from NSDQ)
$1.56 USD
+0.07 (4.70%)
Updated May 28, 2024 04:00 PM ET
After-Market: $1.56 0.00 (0.00%) 6:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Brokerage Reports
0 items in cart
Adicet Bio, Inc. [ACET]
Reports for Purchase
Showing records 81 - 98 ( 98 total )
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
2Q21 Results; ADI-001 Phase 1 Data Expected by Year End
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Q1 Financials; ADI-001 Data on Track for Late 2021
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
1Q21 Results; First Clinical Data Expected Later This Year
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Unleashing the Power of Gamma Delta T Cells; Initiating With a Buy Rating and PT of $27
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Q4 Financials, ADI-001 into the Clinic; Data in 2021
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
First Patient Dosed with ADI-001 with Data Expected by YE; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
ADI-001 IND Cleared With Study Startup in NHL Underway; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Initiating OUTPERFORM and $25 PT: Tooling a Unique T Cell for Tumors
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R